Adenosine-A2a receptor down-regulates cerebral smooth muscle L-type Ca2+ channel activity via protein tyrosine phosphatase, not cAMP-dependent protein kinase. 2003

Katrina Murphy, and Volodymyr Gerzanich, and Hui Zhou, and Svetlana Ivanova, and Yafeng Dong, and Gloria Hoffman, and G Alexander West, and H Richard Winn, and J Marc Simard
Department of Neurosurgery, University of Maryland School of Medicine, 22 South Greene St., Baltimore MD 21201-1595, USA.

Adenosine acting via A2a receptors (A2aR) is a potent cerebral vasodilator that relaxes vascular smooth muscle cells (VSMCs) by a mechanism attributed to activation of cAMP-dependent protein kinase (cAK). We examined effects of adenosine and its mechanism of action on L-type Ca2+ channels in native VSMCs from rat basilar artery. Reverse transcription-polymerase chain reaction and immunofluorescence imaging confirmed transcription and expression of A2aR, and in situ hybridization confirmed presence of mRNA for L-type Cav1.2b channels. In patch-clamp experiments, adenosine down-regulated Ca2+ channel currents in a concentration-dependent manner, with receptor-subtype-specific antagonists [4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo-[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM-241385) versus 1,3-dipropyl-8-cyclopentyl-1,3-dipropylxanthine] showing that this was caused by action of A2aR. Down-regulation of channel currents was mimicked by stimulation of cGMP-dependent protein kinase (cGK; 8-Br-cGMP) and by inhibition of tyrosine kinase (AG-18) but not by stimulation of cAK [forskolin and 8-bromo-cAMP (8-Br-AMP)]. Down-regulation of currents by the A2aR agonist 2-[p-(2-carboxyeth yl)phenylethylamino]-5'-N-ethyolcarboxamidoadenosine (CGS-21680) was blocked by inhibiting protein tyrosine phosphatase (PTP; orthovanodate and dephostatin), but not by inhibiting cGK (KT-5823 and H-7). Western blots of lysate or of immunoisolated Ca2+ channels from arterial segments incubated with CGS-21680 showed 1) increased phosphorylation of vasodilator-stimulated phosphoprotein that was blocked by inhibiting cAK (KT-5720), consistent with activation of cAK by A2aR; and 2) decreased tyrosine phosphorylation of immunoisolated alpha1c subunit of the Ca2+ channel. Our data show that cAK, although activated, was not germane to down-regulation of Ca2+ channel activity by A2aR, and they delineate a novel signaling mechanism involving reduced tyrosine phosphorylation of Ca2+ channels by A2aR probably caused by PTP activation.

UI MeSH Term Description Entries
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001488 Basilar Artery The artery formed by the union of the right and left vertebral arteries; it runs from the lower to the upper border of the pons, where it bifurcates into the two posterior cerebral arteries. Arteries, Basilar,Artery, Basilar,Basilar Arteries
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D017027 Protein Tyrosine Phosphatases An enzyme group that specifically dephosphorylates phosphotyrosyl residues in selected proteins. Together with PROTEIN-TYROSINE KINASE, it regulates tyrosine phosphorylation and dephosphorylation in cellular signal transduction and may play a role in cell growth control and carcinogenesis. Phosphotyrosine Phosphatase,Protein-Tyrosine-Phosphatase,Tyrosyl Phosphoprotein Phosphatase,PTPase,Phosphotyrosyl Protein Phosphatase,Protein-Tyrosine Phosphatase,Phosphatase, Phosphotyrosine,Phosphatase, Phosphotyrosyl Protein,Phosphatase, Protein-Tyrosine,Phosphatase, Tyrosyl Phosphoprotein,Phosphatases, Protein Tyrosine,Phosphoprotein Phosphatase, Tyrosyl,Protein Phosphatase, Phosphotyrosyl,Protein Tyrosine Phosphatase,Tyrosine Phosphatases, Protein
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D043705 Receptor, Adenosine A2A A subclass of adenosine A2 receptors found in LEUKOCYTES, the SPLEEN, the THYMUS and a variety of other tissues. It is generally considered to be a receptor for ADENOSINE that couples to the GS, STIMULATORY G-PROTEIN. Adenosine A2A Receptor,Adenosine A(2A) Receptor,Adenosine A2A Receptors,A2A Receptor, Adenosine,A2A Receptors, Adenosine,Receptors, Adenosine A2A

Related Publications

Katrina Murphy, and Volodymyr Gerzanich, and Hui Zhou, and Svetlana Ivanova, and Yafeng Dong, and Gloria Hoffman, and G Alexander West, and H Richard Winn, and J Marc Simard
February 1997, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Katrina Murphy, and Volodymyr Gerzanich, and Hui Zhou, and Svetlana Ivanova, and Yafeng Dong, and Gloria Hoffman, and G Alexander West, and H Richard Winn, and J Marc Simard
September 1997, Proceedings of the National Academy of Sciences of the United States of America,
Katrina Murphy, and Volodymyr Gerzanich, and Hui Zhou, and Svetlana Ivanova, and Yafeng Dong, and Gloria Hoffman, and G Alexander West, and H Richard Winn, and J Marc Simard
November 1994, Proceedings of the National Academy of Sciences of the United States of America,
Katrina Murphy, and Volodymyr Gerzanich, and Hui Zhou, and Svetlana Ivanova, and Yafeng Dong, and Gloria Hoffman, and G Alexander West, and H Richard Winn, and J Marc Simard
January 1987, Progress in clinical and biological research,
Katrina Murphy, and Volodymyr Gerzanich, and Hui Zhou, and Svetlana Ivanova, and Yafeng Dong, and Gloria Hoffman, and G Alexander West, and H Richard Winn, and J Marc Simard
February 1997, The Journal of biological chemistry,
Katrina Murphy, and Volodymyr Gerzanich, and Hui Zhou, and Svetlana Ivanova, and Yafeng Dong, and Gloria Hoffman, and G Alexander West, and H Richard Winn, and J Marc Simard
December 2013, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Katrina Murphy, and Volodymyr Gerzanich, and Hui Zhou, and Svetlana Ivanova, and Yafeng Dong, and Gloria Hoffman, and G Alexander West, and H Richard Winn, and J Marc Simard
November 1997, The Journal of general physiology,
Katrina Murphy, and Volodymyr Gerzanich, and Hui Zhou, and Svetlana Ivanova, and Yafeng Dong, and Gloria Hoffman, and G Alexander West, and H Richard Winn, and J Marc Simard
June 2002, The Journal of biological chemistry,
Katrina Murphy, and Volodymyr Gerzanich, and Hui Zhou, and Svetlana Ivanova, and Yafeng Dong, and Gloria Hoffman, and G Alexander West, and H Richard Winn, and J Marc Simard
March 2009, The Journal of cell biology,
Katrina Murphy, and Volodymyr Gerzanich, and Hui Zhou, and Svetlana Ivanova, and Yafeng Dong, and Gloria Hoffman, and G Alexander West, and H Richard Winn, and J Marc Simard
October 2012, Molecular medicine reports,
Copied contents to your clipboard!